[DOI] [PMC free article] [PubMed] [Google Scholar] 34.Nazarzadeh M, Bidel Z, Canoy D, Copland E, Bennett DA, Dehghan A, Davey Smith G, Holman RR, Woodward M, Gupta A, Adler AI, Wamil M, Sattar N, Cushman WC, McManus RJ, Teo K, Davis BR, Chalmers J, Pepine CJ, Rahimi K Blood Pressure Lowering Treatment Trialists Collaboration
Nitrofurantoin-induced agranulocytosis
Constipation is one of several gastrointestinal side effects associated with Mounjaro, alongside nausea, vomiting, diarrhea, decreased appetite, and abdominal discomfort
[20] [18] The SUSTAIN-6 findings led to updates in FDA labeling for semaglutide, noting that patients with a history of diabetic retinopathy should be monitored for progression
Given its effects on appetite, nutrition, and metabolism, use during these periods is not recommended
This product is intended for research purposes only and is not approved for human use.